Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 461.00 | 650.00 | 0.7092 | 0.3500 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 7 | 625.00 | 354.63 | 704.00 | 650.00 | 1.0831 | 1.1912 |
| SK-BR-3 | Linsitinib | 1 | uM | 7 | 625.00 | 354.63 | 840.00 | 650.00 | 1.2923 | 1.6818 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 7 | 625.00 | 354.63 | 537.00 | 650.00 | 0.8262 | 0.6075 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 819.00 | 650.00 | 1.2600 | 1.6053 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 7 | 625.00 | 354.63 | 389.00 | 650.00 | 0.5985 | 0.1116 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 7 | 625.00 | 354.63 | 415.00 | 650.00 | 0.6385 | 0.1970 |
| SK-BR-3 | Lapatinib | 1 | uM | 7 | 625.00 | 354.63 | 409.00 | 650.00 | 0.6292 | 0.1773 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 7 | 625.00 | 354.63 | 647.00 | 650.00 | 0.9954 | 0.9894 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 693.00 | 650.00 | 1.0662 | 1.1521 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 7 | 625.00 | 354.63 | 423.00 | 650.00 | 0.6508 | 0.2235 |
| SK-BR-3 | Erlotinib | 10 | uM | 7 | 625.00 | 354.63 | 379.00 | 650.00 | 0.5831 | 0.0790 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 7 | 625.00 | 354.63 | 494.00 | 650.00 | 0.7600 | 0.4611 |
| SK-BR-3 | 17-AAG | 0.0033113 | uM | 7 | 625.00 | 354.63 | 452.00 | 650.00 | 0.6954 | 0.3199 |
| SK-BR-3 | Lapatinib | 10 | uM | 7 | 625.00 | 354.63 | 425.00 | 650.00 | 0.6539 | 0.2301 |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 590.00 | 650.00 | 0.9077 | 0.7903 | |
| SK-BR-3 | 0 | uM | 7 | 625.00 | 354.63 | 5.00 | 650.00 | 0.0077 | -0.9924 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 5.00 | 1850.00 | 0.0027 | -0.9905 | |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 2026.00 | 1850.00 | 1.0951 | 1.1713 | |
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 1250.00 | 859.67 | 1804.00 | 1850.00 | 0.9751 | 0.9550 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 1250.00 | 859.67 | 1744.00 | 1850.00 | 0.9427 | 0.8961 |
| SK-BR-3 | 0 | uM | 7 | 1250.00 | 859.67 | 1971.00 | 1850.00 | 1.0654 | 1.1179 | |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 1250.00 | 859.67 | 808.00 | 1850.00 | 0.4368 | -0.0545 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 1250.00 | 859.67 | 1493.00 | 1850.00 | 0.8070 | 0.6475 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 1250.00 | 859.67 | 953.00 | 1850.00 | 0.5151 | 0.0977 |